Expression of long non-coding RNAs (lncRNAs) has been dysregulated in non-small cell lung cancer tissues

Esfandi, Farbod; Taheri, Mohammad; Omrani, Mir Davood; Shadmehr, Mohammad Behgam; Arsang-Jang, Shahram; Shams, Roshanak; Ghafouri-Fard, Soudeh

doi:10.1186/s12885-019-5435-5

BMC Cancer

Table 5 Association between the relative expression of lncRNAs and independent variables

From: Expression of long non-coding RNAs (lncRNAs) has been dysregulated in non-small cell lung cancer tissues

lncRNAs	Parameters	Beta	SE	t	P-value	95% CI for Beta
NEAT1	Age	0.04	0.13	0.28	0.78	[−0.24, 0.31]
	Gender (Female/Male)	−1.62	2.33	−0.70	0.49	[−6.42, 3.17]
	Smoking (Yes/No)	− 0.84	2.63	−0.32	0.75	[−6.26, 4.57]
	Subtype (SCC/Adeno)	−2.64	1.99	−1.32	0.20	[−6.74, 1.46]
	Stage
	2	0.71	2.62	0.27	0.79	[−4.69, 6.1]
	3	2.70	2.41	1.12	0.27	[−2.26, 7.66]
TUG1	Age	0.19	0.11	1.64	0.11	[−0.05, 0.42]
	Gender (Female/Male)	−3.78	2.00	−1.89	0.07	[−7.89, 0.33]
	Smoking (Yes/No)	1.74	2.26	0.77	0.45	[−2.91, 6.39]
	Subtype (SCC/Adeno)	−3.84	1.71	−2.25	0.03	[−7.36, −0.32]
	Stage
	2	0.05	2.25	0.02	0.98	[−4.57, 4.68]
	3	0.84	2.06	0.41	0.69	[− 3.41, 5.09]
FAS-AS1	Age	0.06	0.15	0.37	0.71	[−0.26, 0.38]
	Gender (Female/Male)	2.23	2.71	0.82	0.42	[−3.34, 7.81]
	Smoking (Yes/No)	−0.50	3.06	−0.16	0.87	[−6.81, 5.81]
	Subtype (SCC/Adeno)	−0.71	2.32	−0.31	0.76	[−5.49, 4.06]
	Stage
	2	−0.61	3.05	−0.20	0.84	[−6.89, 5.67]
	3	0.88	2.80	0.32	0.76	[−4.88, 6.65]
GAS5	Age	0.14	0.13	1.06	0.30	[−0.14, 0.42]
	Gender (Female/Male)	−0.84	2.36	−0.36	0.72	[−5.7, 4.02]
	Smoking (Yes/No)	−2.55	2.67	−0.96	0.35	[−8.05, 2.95]
	Subtype (SCC/Adeno)	−3.73	2.02	−1.84	0.08	[−7.89, 0.44]
	Stage
	2	3.32	2.66	1.25	0.22	[−2.16, 8.79]
	3	3.52	2.44	1.44	0.16	[−1.51, 8.55]
PVT1	Age	0.17	0.13	1.27	0.22	[−0.1, 0.44]
	Gender (Female/Male)	−0.66	2.31	−0.29	0.78	[−5.42, 4.1]
	Smoking (Yes/No)	−1.36	2.62	−0.52	0.61	[−6.74, 4.03]
	Subtype (SCC/Adeno)	−1.74	1.98	−0.88	0.39	[−5.81, 2.34]
	Stage
	2	0.69	2.60	0.27	0.79	[−4.67, 6.05]
	3	1.14	2.39	0.48	0.64	[−3.78, 6.07]
THRIL	Age	0.01	0.16	0.07	0.95	[−0.33, 0.35]
	Gender (Female/Male)	0.52	2.87	0.18	0.86	[−5.39, 6.44]
	Smoking (Yes/No)	0.00	3.25	0.00	>.999	[−6.69, 6.69]
	Subtype (SCC/Adeno)	−2.77	2.46	−1.13	0.27	[−7.84, 2.29]
	Stage
	2	−3.20	3.23	−0.99	0.33	[−9.86, 3.46]
	3	0.19	2.97	0.07	0.95	[−5.93, 6.31]
HOTAIRM1	Age	0.46	0.24	1.94	0.06	[−0.03, 0.96]
	Gender (Female/Male)	−1.92	4.19	−0.46	0.65	[−10.55, 6.72]
	Smoking (Yes/No)	3.57	4.74	0.75	0.46	[−6.19, 13.33]
	Subtype (SCC/Adeno)	− 6.50	3.59	−1.81	0.08	[−13.89, 0.89]
	Stage
	2	0.64	4.72	0.14	0.89	[−9.08, 10.36]
	3	1.24	4.34	0.29	0.78	[−7.68, 10.17]

Back to article page

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com